This paper takes Harry Collins' concept of the `core set' and combines it with emerging work in the sociology of sociotechnical expectations to explore the continued citation in review papers of a research result that is widely rejected by experts. The result in question, a putative pharmacogenetic link between carrying the APOE4 allele and reduced response to the anti-Alzheimer's disease (AD) drug Tacrine, was first reported in 1995. Since then it has been widely cited, helping to create expectations about pharmacogenetics or `personalized medicine'. To the majority of clinicians and researchers specialized in AD (the core set) this result is of little value--both scientifically defunct and ethically risky--although some supporters continue to suggest that the value of the result has been masked by commercial interests. This paper shows how the value of this result as an example of pharmacogenetics leads commentators outside the core set to ignore its controversial qualities and use it as a resource for expectation-building, but in the process producing a representation of AD pharmacogenetics that resembles an `alien science' (an inaccurate picture an outsider conveys of a scientific topic based on the literature, rather than interviews with the scientists involved).
...MoreDescription Explores “the continued citation in review papers of a research result that is widely rejected by experts.” (from the abstract)
Article
Baker, Jonathan D.;
(2011)
Tradition and Toxicity: Evidential Cultures in the Kava Safety Debate
(/isis/citation/CBB001034677/)
Article
Lara Keuck;
(2017)
History as a Biomedical Matter: Recent Reassessments of the First Cases of Alzheimer’s Disease
(/isis/citation/CBB195037038/)
Article
Horwitz, Allan V.;
(2011)
Naming the Problem That Has No Name: Creating Targets for Standardized Drugs
(/isis/citation/CBB001221532/)
Chapter
Daemmrich, A.;
Greene, J.;
(2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
(/isis/citation/CBB001221031/)
Article
Herzberg, David;
(2011)
Blockbusters and Controlled Substances: Miltown, Quaalude, and Consumer Demand for Drugs in Postwar America
(/isis/citation/CBB001221531/)
Article
Balz, Viola;
Hoheisel, Matthias;
(2011)
East-Side Story: The Standardisation of Psychotropic Drugs at the Charité Psychiatric Clinic, 1955--1970
(/isis/citation/CBB001221535/)
Article
Pieters, Toine;
Majerus, Benoît;
(2011)
The Introduction of Chlorpromazine in Belgium and the Netherlands (1951--1968); Tango between Old and New Treatment Features
(/isis/citation/CBB001221534/)
Article
Cook, Harold J.;
(2011)
Markets and Cultures: Medical Specifics and the Reconfiguration of the Body in Early Modern Europe
(/isis/citation/CBB001200553/)
Article
Karamati, Younes;
(2013)
The place of Rāzī's Treatise on Substitute Drugs in the Pharmacological and Pharmaceutical Tradition of the Islamic Period
(/isis/citation/CBB001510297/)
Book
Geissler, Wenzel;
Molyneux, Catherine;
(2011)
Evidence, Ethos and Experiment: The Anthropology and History of Medical Research in Africa
(/isis/citation/CBB001221465/)
Book
Robinson, Joseph D.;
(2001)
Mechanisms of Synaptic Transmission: Bridging the Gap (1890-1990)
(/isis/citation/CBB000102087/)
Article
Quirke, Viviane;
(2006)
Putting Theory into Practice: James Black, Receptor Theory and the Development of the Beta-Blockers at ICI, 1958--1978
(/isis/citation/CBB000773951/)
Article
Li, Runhong;
(2011)
The “523 Project” and the Rediscovery of Sweet Wormwood's Antimalarial Effect
(/isis/citation/CBB001221350/)
Article
Duffin, Jacalyn;
(2002)
Poisoning the Spindle: Serendipity and Discovery of the Anti-Tumor Properties of the Vinca Alkaloids. Part I
(/isis/citation/CBB000300564/)
Article
Gerke, Barbara;
(2013)
The Social Life of Tsotel: Processing Mercury in Contemporary Tibetan Medicine
(/isis/citation/CBB001510478/)
Article
Ashcroft, Richard E.;
Hedgecoe, Adam M.;
(2006)
Genetic Databases and Pharmacogenetics: Introduction
(/isis/citation/CBB000770737/)
Article
Bittencourt, Silvia Cardoso;
Caponi, Sandra;
Maluf, Sonia;
(2013)
Farmacologia no século XX: a ciência dos medicamentos a partir da análise do livro de Goodman e Gilman
(/isis/citation/CBB001420651/)
Article
Benoît Majerus;
(2019)
A Chemical Revolution as Seen from below: The ‘Discovery’ of Neuroleptics in 1950s Paris
(/isis/citation/CBB218045654/)
Article
Aschoff, Jürgen C.;
(2013)
A Physician's View on Legal Aspects of the Contemporary Medical Use of Mercury in Germany
(/isis/citation/CBB001510481/)
Book
Epstein, Steven G.;
(2007)
Inclusion: The Politics of Difference in Medical Research
(/isis/citation/CBB000950680/)
Be the first to comment!